| Literature DB >> 34136026 |
Yi Sun1, Lei Lian2, Hong Zhang3, Xuefeng Bai4, Zhongshi Xie5, Jun Ouyang6, Kai Wang7, Hang Yuan8, Chang Xu9, Henggui Luo10, Haijun Deng11, Jun Li12, Hongjie Yang1, Zhichun Zhang1, Peng Li1, Xipeng Zhang1.
Abstract
INTRODUCTION: Laparoscopic lateral lymph node dissection (LLND) is an important treatment for patients with lateral lymph node metastasis. AIM: To assess the technical feasibility and investigate the surgical outcomes after LLND using the fascia space priority approach for patients with advanced middle and low rectal cancer.Entities:
Keywords: fascia space priority approach; lateral lymph node dissection; rectal cancer; surgical technology
Year: 2021 PMID: 34136026 PMCID: PMC8193747 DOI: 10.5114/wiitm.2021.105143
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.195
Figure 1Medical centres and number of cases
Photo 1Establishment of 3 anatomic fascia spaces. A – Intraoperative view after dissection of the first anatomic fascia space between the ureterohypogastric nerve fascia and the medial aspect of the vesicohypogastric fascia. B – Intraoperative view after dissection of the second anatomic fascia space between the vesicohypogastric fascia and the obturator lymph nodes. NO 283, number 283 (obturator region) lymph nodes; ATFP, arch of the tendinous pelvic fascia. C – View of the first and the second anatomic fascia spaces. NO 263, number 263 (internal iliac region) lymph nodes. D – Intraoperative view after dissection of the third anatomic fascia space between the parietal pelvic fascia and the obturator lymph nodes. E – View of the dorsal wall. F – The locations of the lateral lymph node groups [9]
UA – umbilical artery, SVA – superior vesical artery, UtA – uterine artery, EIA – external iliac artery, VHGF – vesicohypogastric fascia, IIA – internal iliac artery, IIV – internal iliac vein, UHGNF – ureterohypogastric nerve fascia, GFN – genitofemoral nerve, CIA – common iliac artery, CIV – common iliac vein, Ur – ureter, OA – ovarian vessels, OIF – obturator internus fascia, IPF – iliopsoas fascia, EIV – external iliac vein, EIA – external iliac artery, SNF – sciatic nerve fascia, ON – obturator nerve.
Photo 2Intraoperative view after lateral lymph node dissection. A – The surgical field after dissection of the lateral lymph nodes. B – View of the lateral, dorsal, and medial walls. C – Communication between the LLND and TME compartments [9]
BL – bladder, IPA – iliopsoas muscle, UHPNF – ureterohypogastric nerve fascia, SFLani – superior fascia of the levator ani.
Patient characteristics (n = 112)
| Variable | Value |
|---|---|
| Age [years] | 56 ±13.1 |
| Sex, | |
| Male | 68 (60.7) |
| Female | 44 (39.3) |
| BMI [kg/m2] | 24.1 ±3.2 |
| Distance to tumour from AV [cm] mean (range) | 4.5 (0–10.0) |
| Preoperative clinical stage: | |
| I | 1 (0.9) |
| II | 23 (20.5) |
| III | 88 (78.6) |
| History of abdominal operation, | 20 (17.9) |
| nCRT, | 58 (49.1) |
BMI – body mass index, AV – anal verge.
Surgical outcomes (n = 112)
| Variable | Value |
|---|---|
| Operation time [min] | 343.6 ±103.8 |
| Blood loss [ml] mean (range) | 100 (10–700) |
| Post-operative hospital stay [days] median (range) | 13 (4–34) |
| Lateral lymph node dissection, | |
| Unilateral | 74 (66.1) |
| Bilateral | 38 (33.9) |
| Conversion, | 0 (0) |
Post-operative complications (n = 112)
| Variable | Value |
|---|---|
| Perioperative complications, | |
| Postoperative haemorrhage | 0 (0) |
| Lymphatic leak | 3 (2.7) |
| Lymphatic cyst | 4 (3.6) |
| Urine leak | 0 (0) |
| Long-term urinary retention (≥ 3 months) | 0 (0) |
| Anastomotic leakage | 4 (3.6) |
| Intestinal obstruction | 4 (3.6) |
| Lower extremity oedema | 3 (2.7) |
| Lower limb pain | 0 (0) |
| Lower limb mobility disorder | 0(0) |
| Total complications rate, | 16 (14.3) |
| Perioperative mortality, | 0 |
| Re-operation rate, | 0 |
Clinical data of nCRT and no nCRT
| Variable | nCRT ( | No nCRT ( | |
| Age [years] | 51.5 ±12.4 | 61.1 ±10.9 | < 0.001 |
| Sex, | |||
| Male | 32 (58.2) | 36 (63.2) | 0.70 |
| Female | 23 (41.8) | 21 (36.8) | |
| BMI [kg/m2] | 23.7 ±2.9 | 24.0 ±3.5 | 0.61 |
| Operation time [min] | 352.2 ±110.7 | 335.3 ±97.0 | 0.40 |
| Blood loss [ml] mean (range) | 100 (20–700) | 100 (10–500) | 0.90 |
| Post-operative hospital stay [days] median (range) | 13.5 (4-34) | 12 (7–33) | 0.58 |
| Lateral lymph node dissection, | |||
| Unilateral | 34 (61.8) | 40 (70.2) | 0.43 |
| Bilateral | 21 (38.2) | 17 (29.8) | |
| Number of patients with positive lateral lymph nodes, | 21 (38.2) | 23 (40.4) | 0.85 |
| Complication rate (Clavien-Dindo I, II), | 8 (14.5) | 11 (19.3) | 0.62 |
| Complication rate (Clavien-Dindo III, IV), | 0 (0) | 0 (0) | |
Clinical data of unilateral group and bilateral group
| Variable | Unilateral ( | Bilateral ( | |
|---|---|---|---|
| Age [years] | 57.0 ±13.1 | 55.3 ±11.7 | 0.51 |
| Sex, | |||
| Male | 48 (64.9) | 20 (52.6) | 0.23 |
| Female | 26 (35.1) | 18 (47.4) | |
| BMI [kg/m2] | 23.9 ±3.3 | 23.6 ±3.2 | 0.64 |
| Operation time [min] | 316.8 ±89.4 | 395.1 ±111.2 | 0.00 |
| Blood loss [ml] mean (range) | 100 (10–700) | 200 (20–700) | 0.01 |
| Post-operative hospital stay [days] median (range) | 12 (4–33) | 13.5 (7–34) | 0.07 |
| nCRT, | 34 (45.9) | 21 (55.3) | 0.43 |
| Number of patients with positive lateral lymph nodes, | 21 (38.2) | 23 (40.4) | 0.85 |
| Complications rate (Clavien-Dindo I, II), | 10 (13.5) | 9 (23.7) | 0.19 |
| Complications rate (Clavien-Dindo III, IV), | 0 (0) | 0 (0) | |
Clinicopathological characteristics (n = 112)
| Variable | Value |
|---|---|
| TNM stage, | |
| 0 | 4 (3.6) |
| I | 7 (6.2) |
| II | 35 (31.3) |
| III | 66 (58.9) |
| Number of lymph nodes per each side | 6 (1–41) |
| Number of patients with positive lateral lymph nodes, | 44 (39.3) |